Results 101 to 110 of about 11,707 (151)

Targeting Key Enzymatic Snake Venom Proteins Using Repurposed Small Molecule Inhibitors: Emerging Adjuncts to Antivenom Therapy. [PDF]

Int J Mol Sci
Reghu N, Kiruthika S, Santhosh AK, Narayanan AL, Geetha KG, Sidheek N, Danthuluri SS, Nair BG, Vanuopadath M.   +8 more
europepmc   +1 more source

Effects of Cape Cobra (<i>Naja nivea</i>) Venom and Its Isolated Protein on the Modulation of Platelet Activation. [PDF]

Toxins (Basel)
Khatibi M, Almeida JR, Al Juwaiser A, Gilabadi S, Patel K, Vaiyapuri S.   +5 more
europepmc   +1 more source

A Paradigm Shift in Snakebite Envenoming Therapy: From Conventional Antivenoms to Rationally Designed, Broadly Neutralizing Combination Therapies. [PDF]

ACS Pharmacol Transl Sci
Shi N, Wang J, Xu C, Jiang X, Ren C, Gao X, Luo L.   +6 more
europepmc   +1 more source

Animal models in venom and antivenom research: The need to align academic discovery with manufacturing and regulatory expectations. [PDF]

PLoS Negl Trop Dis
Ainsworth S, Casewell NR, Sartim MA, Marriott AE, Gutiérrez JM.   +4 more
europepmc   +1 more source

A developmental shift in venom toxin expression underpins a major prey switch in Australian brown snakes. [PDF]

BMC Biol
van Thiel J, Smith CF, Kazandjian TD, Patel RN, Cullen IC, French S, Da Silva R, Albulescu LO, Dunstan N, Kool J, Richardson MK, Mackessy SP, Casewell NR, Kini RM, Saviola AJ, Jackson TNW, Modahl CM.   +16 more
europepmc   +1 more source

The 21-nanometer window: How endothelial pores reshape our understanding of antigen dissemination. [PDF]

J Physiol
Rodrigues EOAL, da Costa MAS, Fabel JA, Souza-Silva GA.   +3 more
europepmc   +1 more source

Adjunctive Varespladib after antivenom administration for snakebite: A phase II randomized clinical trial. [PDF]

PLoS Negl Trop Dis
Gerardo CJ, Bhalla A, Mohanty CR, Sahu BK, Kumar S, Agrawal S, Ayyan S M, Shu E, Deuson T, Kumar R M, Beatty NL, Akpunonu PD, Shirazi FM, Watkins S, Ruha AM, Varney SM, Goel AK, Gautam M, Arnold J, Bammigatti C, Francis SJ, Selvam S, Kumar H, Aizenberg A, Micciche A, Bledsoe RS, Boatright G, Oomman SC, Samuel SP, Wittes JT, Carter RW, Lewin MR, Platts-Mills TF.   +32 more
europepmc   +1 more source

Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites. [PDF]

Nature
Ahmadi S, Burlet NJ, Benard-Valle M, Guadarrama-Martínez A, Kerwin S, Cardoso IA, Marriott AE, Edge RJ, Crittenden E, Neri-Castro E, Fernandez-Quintero ML, Nguyen GTT, O'Brien C, Wouters Y, Kalogeropoulos K, Thumtecho S, Ebersole TW, Dahl CH, Glegg-Sørensen EU, Jansen T, Boddum K, Manousaki E, Rivera-de-Torre E, Ward AB, Morth JP, Alagón A, Mackessy SP, Ainsworth S, Menzies SK, Casewell NR, Jenkins TP, Ljungars A, Laustsen AH.   +32 more
europepmc   +1 more source

Screening the antimicrobial properties of snake venoms: an iterative fractionation approach. [PDF]

Access Microbiol
Fraser AJ, Wilkinson MC, Meehan CJ, Casewell NR, Roberts AP, Hubbard ATM.   +5 more
europepmc   +1 more source

Nature's antivenom: Combinations of conserved rattlesnake serum metalloproteinase inhibitors block the lethal action of viper venoms. [PDF]

Proc Natl Acad Sci U S A
Carroll SB, Ukken FP, Ayinuola YA, Escalona L, Suntravat M, Sanchez EE.   +5 more
europepmc   +1 more source